2seventy bio, Inc.
TSVTDelisted May 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860782
2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by 2seventy bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for 2seventy bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Casdin Partners GP, LLC | Director | 0Indirect | May 15, 2025 | 0 |
| Casdin Capital, LLC | Director | 0Indirect | May 15, 2025 | 0 |
| Casdin Eli | Director | 0Indirect | May 15, 2025 | 0 |
| Casdin Partners Master Fund, L.P. | Director | 0Indirect | May 15, 2025 | 0 |
| Baird William D III | President and CEO | 0 | May 15, 2025 | 0 |
| Leschly Nick | Director | 0Indirect | May 15, 2025 | 0 |
| Glickman Sarah JS | Director | 0 | May 15, 2025 | 0 |
| Torres Denice | Director | 0 | May 15, 2025 | 0 |
| Newton Charles W. | Director | 0 | May 15, 2025 | 0 |
| Wei Lin | Director | 0 | May 15, 2025 | 0 |
| Maus Marcela V. | Director | 0 | May 15, 2025 | 0 |
| Snow Jessica | Chief Operating Officer | 0 | May 15, 2025 | 0 |
| Eatwell Victoria | Chief Financial Officer | 0 | May 15, 2025 | 0 |
| Kynam Capital Management, LP | 10% Owner | 0Indirect | Mar 13, 2025 | 0 |
| Kynam Capital Management GP, LLC | 10% Owner | 0Indirect | Mar 13, 2025 | 0 |
| Kynam Global Healthcare Master Fund, LP | 10% Owner | 0Indirect | Mar 13, 2025 | 0 |
| Kynam Fund GP, LLC | 10% Owner | 0Indirect | Mar 13, 2025 | 0 |
| Tang Yue | 10% Owner | 0Indirect | Mar 13, 2025 | 0 |
| Gregory Philip D | Chief Scientific Officer | 310,280 | Jan 9, 2024 | 0 |
| Lynch Daniel | Director | 21,053 | Jun 15, 2023 | 0 |
| Ibrahim Ramy | Director | 19,050 | Jun 15, 2023 | 0 |
| Heffron Nicola | Chief Operating Officer | 89,182 | Feb 9, 2023 | 0 |
| Sellers William R. | Director | 3,202 | Nov 16, 2021 | 0 |
| bluebird bio, Inc. | 10% Owner | 0 | Nov 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Eatwell VictoriaChief Financial Officer | SSale | −13 | $3.99 | −$51.87 | 0.0%341.3K after | |
| Aug 16, 2024 (view filing) | Aug 14 | 2 days | Snow JessicaSee Remarks | SSale | −7.82K | $4.32 | −$33.8K | −4.8%156.3K after | |
| Oct 7, 2024 (view filing) | Oct 3 | 4 days | Eatwell VictoriaChief Financial Officer | SSale | −1.23K | $4.65 | −$5.72K | −0.4%340.1K after | |
| Oct 7, 2024 (view filing) | Oct 3 | 4 days | Snow JessicaSee Remarks | SSale | −679 | $4.65 | −$3.16K | −0.4%155.8K after | |
| Nov 20, 2024 (view filing) | Nov 18 | 2 days | Maus Marcela V.Director | SSale | −3.90K | $3.38 | −$13.2K | −14.1%23.8K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Snow JessicaSee Remarks | SSale | −2.29K | $3.23 | −$7.39K | −1.5%153.5K after | 10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Baird William D IIIPresident and CEO | SSale | −32.5K | $2.94 | −$95.4K | −3.6%862.1K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Eatwell VictoriaChief Financial Officer | SSale | −1.11K | $2.93 | −$3.25K | −0.3%339.0K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Leschly NickDirector | SSale | −86.9K | $2.94 | −$255.3K | −6.6%1.23M after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-7 | 4 days | Snow JessicaSee Remarks | SSale | −6.19K | $2.81 | −$17.4K | −4.0%147.2K after | From original3 lots10b5-1 |
| Jan 22, 2025 (view filing) | Jan 6 | 16 days | Snow JessicaSee Remarks | SSale | −1.84K | $2.79 | −$5.13K | −1.2%150.5K after | Amended10b5-1 |
| Mar 13, 2025 (view filing)6:18 PM ET | Mar 11 | 2 days | Kynam Capital Management, LP and 4 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −11.1M | $4.93 | −$54.7M | −100.0%0 after | 2 lots |
| Mar 13, 2025 (view filing)6:18 PM ET | Mar 11 | 2 days | Kynam Capital Management, LP and 4 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −5.14M | $4.93 | −$25.4M | −100.0%0 after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Eatwell VictoriaChief Financial Officer | SSale | −2.59K | $4.95 | −$12.8K | −0.6%444.4K after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Baird William D IIIPresident and CEO | SSale | −5.09K | $4.95 | −$25.2K | −0.5%1.12M after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Snow JessicaChief Operating Officer | SSale | −2.30K | $4.95 | −$11.4K | −0.9%254.2K after | 10b5-1 |